High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
Carol Fabian, MD · NCT00291096
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 30–65 · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 3000
- US sites recruiting
- 1
- Study start
- August 1989
- Record last updated
- October 29, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
Conditions: Breast Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- women with at least 2 times the normal risk of developing breast cancer
- between the ages of 30-65 (or within 10 years of youngest age at diagnosis in first degree relative)
- greater than six months from ingestion of antihormonal therapy
- greater than 1 year from pregnancy, lactation, or chemotherapy
- willing to have a mammogram within six months prior to RPFNA
- willing to discontinue NSAIDS or herbal supplements
- willing to have blood drawn
Exclusion Criteria
- no metastatic malignancy of any kind
- no breast implants or tram flap reconstructions
- no radiation to both breasts
- no women who have a current mammogram or clinical breast exam suspicious for cancer
Recruiting US locations
University of Kansas Medical Center
Kansas City, KS 66160
Site contact: Carol J Fabian, MD
Study contacts (from the official record)
- Bruce Kimler, Ph.D. · 913-588-4523 · bkimler@kumc.edu
Similar studies in Kansas
All healthy volunteers studies in Kansas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Basilea Pharmaceutica
- Location
- Lenexa, KS
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Newton, KS + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Evaluation of VX-581 in Healthy Participants and in Participants With Cystic Fibrosis
Vertex Pharmaceuticals Incorporated
- Location
- Overland Park, KS
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study of RO7890597 in Healthy Adult Volunteers
Genentech, Inc.
- Location
- Lenexa, KS
- Eligibility basics
- Ages 18–65